BioSenic S.A. (BIOS) - Cash Flow Conversion Efficiency

Latest as of December 2024: 0.052x

Based on the latest financial reports, BioSenic S.A. (BIOS) has a cash flow conversion efficiency ratio of 0.052x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-1.39 Million ≈ $-1.62 Million USD) by net assets (€-26.81 Million ≈ $-31.34 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

BioSenic S.A. - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how BioSenic S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of BioSenic S.A. for a breakdown of total debt and financial obligations.

BioSenic S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BioSenic S.A. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Trufin PLC LSE:TRU	0.203x
WORK Medical Technology Group LTD Ordinary Shares NASDAQ:WOK	0.427x
Lazydays Holdings Inc NASDAQ:GORV	0.889x
Anatara Lifesciences Ltd AU:ANR	-2.561x
Foxtons Group Plc LSE:FOXT	0.081x
Shirpur Gold Refinery Limited NSE:SHIRPUR-G	-0.008x
Oncternal Therapeutics Inc NASDAQ:ONCT	-0.760x
Golden Cross Resources Ltd AU:GCR	-0.040x

Annual Cash Flow Conversion Efficiency for BioSenic S.A. (2012–2024)

The table below shows the annual cash flow conversion efficiency of BioSenic S.A. from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see market value of BioSenic S.A..

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-26.81 Million ≈ $-31.34 Million	€-2.23 Million ≈ $-2.61 Million	0.083x	-45.50%
2023-12-31	€-22.70 Million ≈ $-26.54 Million	€-3.47 Million ≈ $-4.06 Million	0.153x	+125.00%
2022-12-31	€3.12 Million ≈ $3.65 Million	€-1.91 Million ≈ $-2.23 Million	-0.611x	-132.35%
2021-12-31	€-6.76 Million ≈ $-7.91 Million	€-12.78 Million ≈ $-14.95 Million	1.890x	+139.07%
2020-12-31	€3.33 Million ≈ $3.89 Million	€-16.08 Million ≈ $-18.80 Million	-4.837x	+4.75%
2019-12-31	€2.05 Million ≈ $2.39 Million	€-10.40 Million ≈ $-12.16 Million	-5.078x	-76.78%
2018-12-31	€4.49 Million ≈ $5.25 Million	€-12.90 Million ≈ $-15.08 Million	-2.873x	+37.87%
2017-12-31	€2.38 Million ≈ $2.79 Million	€-11.02 Million ≈ $-12.88 Million	-4.624x	-521.01%
2016-12-31	€15.27 Million ≈ $17.85 Million	€-11.37 Million ≈ $-13.29 Million	-0.745x	-78.12%
2015-12-31	€28.15 Million ≈ $32.91 Million	€-11.77 Million ≈ $-13.75 Million	-0.418x	-212.50%
2014-12-31	€-9.48 Million ≈ $-11.09 Million	€-3.52 Million ≈ $-4.12 Million	0.372x	+100.71%
2013-12-31	€63.00K ≈ $73.65K	€-3.27 Million ≈ $-3.83 Million	-51.968x	-3284.99%
2012-12-31	€2.64 Million ≈ $3.08 Million	€-4.05 Million ≈ $-4.73 Million	-1.535x	--

About BioSenic S.A.

BR:BIOS Belgium Biotechnology

Market Cap

$1.68 Million

€1.44 Million EUR

Market Cap Rank

#29902 Global

#110 in Belgium

Share Price

€0.00

Change (1 day)

+0.00%

52-Week Range

€0.00 - €0.00

All Time High

€20.66